Peptides at a Crossroads: What Wellness Providers Need to Know About HHS and FDA Actions

A news report in early October 2026 indicated that the U.S. Department of Health and Human Services (HHS) is preparing a temporary measure that would let certain compounding pharmacies dispense some previously restricted peptides while the U.S. Food and Drug Administration (FDA) develops formal regulations. The report, which relies on two unnamed sources, has led some media outlets to describe the FDA as “fast-tracking” peptides….
By: Holland & Knight LLP